Cronos Group Inc vs Emerson Electric Co. — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Emerson Electric Co. trades at $159.06 (market cap $88.72B). The key difference: Emerson Electric Co. is far larger — about 75.2× Cronos Group Inc's market cap, and Emerson Electric Co. pays a 1.4% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Emerson Electric Co. for 81 Days on average.
| CRON | EMR | |
|---|---|---|
Market Cap | $1.18B | $88.72B |
Volume | 968,037 | 2,355,255 |
Sector | Health | Industrials |
52-Week High | $3.55 | $164.38 |
52-Week Low | $2.30 | $123.30 |
Typical Hold Time | 22 Days | 81 Days |
Enterprise Value | $387.62M | $99.80B |
Dividend Yield | — | 1.4% |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Emerson Electric (EMR) trades at $159.22, down 1.34% on the day, near its pivot point of $159. The stock shows a bullish technical trend with moving averages supporting upside momentum. Fundamentally, EMR delivered three consecutive quarterly earnings beats, with Q2 2026 EPS of $1.71 exceeding the $1.68 estimate. Revenue growth is steady, projected to reach $18.6B in 2026, while profitability remains solid with a net income margin of 13.83% in 2025.
The outlook for EMR is positive, supported by analyst consensus favoring a Buy rating (53.49%) and a $165.90 price target implying ~4% upside. Key risks include volatile cash flows, with net cash flow negative in 2025, and elevated debt levels. Investor sentiment is bolstered by strong institutional coverage and recent dividend declarations, though macroeconomic pressures on industrials warrant caution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →